Skip to Content Skip to Content

Health & Medicine

Enhanced CAR T cell therapy offers new strategy for lymphoma
3-D rendering of chimeric antigen receptor T (CAR-T) cell therapy, a treatment for a variety of cancers

Image: iStock/Naeblys

Enhanced CAR T cell therapy offers new strategy for lymphoma

A new study from Penn Medicine marks a significant development in the ongoing evolution of CAR T cell therapy, as a novel cytokine-enhanced CAR T that has been tested in patients with blood cancer shows robust response rates.

2 min. read

First new subtype of Castleman disease discovered in 45 years
David Fajgenbaum in his lab.

David Fajgenbaum is an assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania and associate director of patient impact in the Penn Orphan Disease Center. He also leads the Castleman Disease Research Program.

(Image: Courtesy of Penn Medicine)

First new subtype of Castleman disease discovered in 45 years

A new study co-authored by Penn Medicine’s David Fajgenbaum expands the spectrum of the rare disorder, which will help diagnose and treat patients caught between existing classification systems.

2 min. read

Study suggests parents of preterm infants miss more postpartum care

Study suggests parents of preterm infants miss more postpartum care

Researchers from the Leonard Davis Institute have investigated whether the intensive focus on neonatal care for preterm infants may come at the expense of critical maternal follow-up, and recommend integrating maternal health care into the NICU.

From Penn LDI

2 min. read

Penn Dental Medicine renews MOU with Jagiellonian University Medical College

Penn Dental Medicine renews MOU with Jagiellonian University Medical College

The renewed MOU, signed by Penn Dental Medicine’s Morton Amsterdam Dean, Dr. Mark Wolff, and Penn Dental professor Uri Hangorsky, will further strengthen the partnership, facilitating joint research projects, faculty exchanges, and student programs.

National Academy of Sciences elects four from Penn
Four headshots of Penn Faculty. Top left tile clockwise: Mark Devlin, Katalin Karikó, E. John Wherry III, and Virginia M.Y. Lee

Four faculty have been elected to the National Academy of Sciences in recognition of their innovative contributions to original scientific research. The newly honored scholars are Mark Devlin (top left) from the School of Arts & Sciences and Katalin Karikó (top right), Virginia M.Y. Lee (bottom left), and E. John Wherry III (bottom right) from the Perelman School of Medicine.

nocred

National Academy of Sciences elects four from Penn

The newly elected members, recognized for their innovative contributions to original research, are Mark Devlin of the School of Arts & Sciences and Katalin Karikó, Virginia Lee, and E. John Wherry III of the Perelman School of Medicine.

3 min. read

The reimagineers of Penn Medicine
Raina Merchant and two staffers in an office looking at a computer at Penn Medicine.

Raina Merchant (right) is an emergency physician and Penn Medicine’s chief transformation officer.

(Image: Courtesy of Penn Medicine News)

The reimagineers of Penn Medicine

Penn Medicine is harnessing innovation and cutting-edge technology to health care, from developing new treatments to streamlining management and improving leadership.

Christina Hernandez-Sherwood

2 min. read